Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117638862> ?p ?o ?g. }
- W2117638862 endingPage "7168" @default.
- W2117638862 startingPage "7156" @default.
- W2117638862 abstract "A cure for prostate cancer (CaP) will be possible only after a complete understanding of the mechanisms causing this disease to progress from androgen dependence to androgen independence. To carry on a careful characterization of the phenotypes of CaP cell lines before and after acquisition of androgen independence, we used two human CaP LNCaP sublines: LNCaP(nan), which is androgen dependent (AD), and LNCaP-HP, which is androgen independent (AI). In AD LNCaP(nan) cells, dihydrotestosterone (DHT) stimulated in an androgen receptor (AR)-dependent way a phosphorylation signaling pathway involving steroid receptor coactivator (Src)-mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase (MEK)-1/2-ERK-1/2-cAMP-response element binding-protein (CREB). Activation of this pathway was associated with increased [(3)H]thymidine incorporation and resistance to apoptosis. Use of dominant-negative forms of MEK-1/2 and CREB demonstrated in LNCaP(nan) cells that DHT induced [(3)H]thymidiine incorporation through a thus far unidentified molecule activated downstream of MEK-1/2, and antiapoptosis through phosphorylation of the transcription factor CREB. In contrast, in AI LNCaP-HP cells, the Src-MEK-1/2-ERK-1/2-CREB pathway was constitutively active. Because it was not further stimulated by addition of DHT, no increase of [(3)H]thymidine incorporation or apoptosis resistance was demonstrated in LNCaP-HP cells. Additional experiments showed that Src and the scaffold protein MNAR coimmunoprecipitated with AR, indicating a role for Src as an apical molecule in the Src-MEK-1/2-ERK-1/2-CREB pathway. Interestingly, differences between the two cell lines were that in LNCaP-HP cells presence of an AI phenotype and lack of response to DHT were associated with constitutive activation of the protein kinase Src and interaction among Src, AR, and MNAR. In contrast, in LNCaP(nan) cells, presence of an AD phenotype and ability to respond to DHT were associated with DHT-dependent activation of Src kinase activity and interaction among Src, AR, and MNAR. Intriguingly, in LNCaP(nan) cells, we found that transcription through the prototypical CREB-responsive promoter c-fos could be induced in a DHT-dependent way, and this action was inhibited by the AR antagonist Casodex and MEK-1 inhibitor PD98059. In contrast, transcription through the PSA P/E promoter, a prototypical AR-dependent promoter directly activated by agonist, was obliterated only by Casodex. Additional experiments with genital skin fibroblasts derived from patients with a variety of AR abnormalities indicated that nongenotropic AR signaling does not depend on an intact DNA-binding domain or on the ability of AR to translocate to the nucleus. The results suggest the following: (1) Constitutive activation of the Src-MEK-1/2-ERK-1/2-CREB pathway is associated with the AI phenotype observed in LNCaP-HP cells. (2) Activation of the Src-MEK-1/2-ERK-1/2-CREB pathway is DHT dependent in AD LNCaP(nan) cells. (3) DHT activation of this pathway is associated with induction of [(3)H]thymidine incorporation by a molecule activated downstream of MEK-1/2 and of antiapoptosis through activation of the transcription factor CREB in AD LNCaP(nan) cells. (4) AR regulates transcription either directly upon ligand binding and nuclear translocation or indirectly through kinase pathways leading to activation of downstream transcription factors. (5) Nuclear translocation and ability of the DNA-binding domain of AR to interact with DNA are not prerequisites for nongenotropic AR activity." @default.
- W2117638862 created "2016-06-24" @default.
- W2117638862 creator A5004362137 @default.
- W2117638862 creator A5016728412 @default.
- W2117638862 creator A5063490051 @default.
- W2117638862 creator A5067548667 @default.
- W2117638862 creator A5070135589 @default.
- W2117638862 creator A5079531814 @default.
- W2117638862 creator A5081189254 @default.
- W2117638862 date "2004-10-01" @default.
- W2117638862 modified "2023-10-04" @default.
- W2117638862 title "Changes in Androgen Receptor Nongenotropic Signaling Correlate with Transition of LNCaP Cells to Androgen Independence" @default.
- W2117638862 cites W1531051436 @default.
- W2117638862 cites W1580523172 @default.
- W2117638862 cites W1594706458 @default.
- W2117638862 cites W1662062786 @default.
- W2117638862 cites W1964280812 @default.
- W2117638862 cites W1964460706 @default.
- W2117638862 cites W1967932707 @default.
- W2117638862 cites W1977704448 @default.
- W2117638862 cites W1979502832 @default.
- W2117638862 cites W1988679331 @default.
- W2117638862 cites W1994110056 @default.
- W2117638862 cites W1995142571 @default.
- W2117638862 cites W1996732665 @default.
- W2117638862 cites W1998476721 @default.
- W2117638862 cites W2001311345 @default.
- W2117638862 cites W2001521752 @default.
- W2117638862 cites W2002249801 @default.
- W2117638862 cites W2003955264 @default.
- W2117638862 cites W2003985632 @default.
- W2117638862 cites W2005658600 @default.
- W2117638862 cites W2005766913 @default.
- W2117638862 cites W2006720525 @default.
- W2117638862 cites W2008171352 @default.
- W2117638862 cites W2011902466 @default.
- W2117638862 cites W2023654765 @default.
- W2117638862 cites W2030565228 @default.
- W2117638862 cites W2032432671 @default.
- W2117638862 cites W2036476604 @default.
- W2117638862 cites W2038421530 @default.
- W2117638862 cites W2050202520 @default.
- W2117638862 cites W2068252839 @default.
- W2117638862 cites W2075767511 @default.
- W2117638862 cites W2078802143 @default.
- W2117638862 cites W2081524299 @default.
- W2117638862 cites W2088359631 @default.
- W2117638862 cites W2091833454 @default.
- W2117638862 cites W2098963564 @default.
- W2117638862 cites W2101244702 @default.
- W2117638862 cites W2101443436 @default.
- W2117638862 cites W2110687233 @default.
- W2117638862 cites W2121881330 @default.
- W2117638862 cites W2125367143 @default.
- W2117638862 cites W2136047735 @default.
- W2117638862 cites W2140855177 @default.
- W2117638862 cites W2144924096 @default.
- W2117638862 cites W2146293896 @default.
- W2117638862 cites W2159092431 @default.
- W2117638862 cites W2160084272 @default.
- W2117638862 cites W2166103492 @default.
- W2117638862 cites W2172256092 @default.
- W2117638862 cites W2313054549 @default.
- W2117638862 cites W2401917646 @default.
- W2117638862 cites W2589976047 @default.
- W2117638862 cites W4232934018 @default.
- W2117638862 cites W4233274199 @default.
- W2117638862 cites W4253767033 @default.
- W2117638862 cites W4385847909 @default.
- W2117638862 cites W2153349062 @default.
- W2117638862 doi "https://doi.org/10.1158/0008-5472.can-04-1121" @default.
- W2117638862 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15466214" @default.
- W2117638862 hasPublicationYear "2004" @default.
- W2117638862 type Work @default.
- W2117638862 sameAs 2117638862 @default.
- W2117638862 citedByCount "210" @default.
- W2117638862 countsByYear W21176388622012 @default.
- W2117638862 countsByYear W21176388622013 @default.
- W2117638862 countsByYear W21176388622014 @default.
- W2117638862 countsByYear W21176388622015 @default.
- W2117638862 countsByYear W21176388622016 @default.
- W2117638862 countsByYear W21176388622017 @default.
- W2117638862 countsByYear W21176388622018 @default.
- W2117638862 countsByYear W21176388622019 @default.
- W2117638862 countsByYear W21176388622020 @default.
- W2117638862 countsByYear W21176388622021 @default.
- W2117638862 countsByYear W21176388622022 @default.
- W2117638862 countsByYear W21176388622023 @default.
- W2117638862 crossrefType "journal-article" @default.
- W2117638862 hasAuthorship W2117638862A5004362137 @default.
- W2117638862 hasAuthorship W2117638862A5016728412 @default.
- W2117638862 hasAuthorship W2117638862A5063490051 @default.
- W2117638862 hasAuthorship W2117638862A5067548667 @default.
- W2117638862 hasAuthorship W2117638862A5070135589 @default.
- W2117638862 hasAuthorship W2117638862A5079531814 @default.
- W2117638862 hasAuthorship W2117638862A5081189254 @default.
- W2117638862 hasBestOaLocation W21176388621 @default.
- W2117638862 hasConcept C104317684 @default.